AMG:ETR
Amgen Inc
413,55 €
arrow_downward
-0,07%(-0,30) 1 d.
9. nov., 17:35:42 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: AMG…
Atvērt
414,00 €
Augsta
416,75 €
Zema
408,20 €
Tirgus kapitalizācija
251,65 mljrd.
Vid. apjoms
548,00
Apjoms
881,00
Augstākā 52 ned.
438,75 €
Zemākā 52 ned.
267,60 €
Darbinieku skaits
32 tūkst.
Atvērt
414,00 €
Augsta
416,75 €
Zema
408,20 €
Tirgus kapitalizācija
251,65 mljrd.
Vid. apjoms
548,00
Apjoms
881,00
Augstākā 52 ned.
438,75 €
Zemākā 52 ned.
267,60 €
Darbinieku skaits
32 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
MarketWatch
·
pirms 1 stundas
Amgen Inc. stock rises Monday, still underperforms market
Yahoo Finance UK
·
pirms 10 stundām
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
24/7 Wall St.
·
pirms 1 dienas
Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today
Amgen
·
pirms 5 dienām
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Profils
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Par “Amgen Inc”
ĢenerāldirektorsRobert A. Bradway
Darbinieki31,5 tūkst.
Dibināšanas datums1980
Galvenais birojsTauzandoksa, Kalifornija, Amerikas Savienotās Valstis
SektorsHealth Care
Nozare-
Tīmekļa vietneamgen.com